Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis

Indian Journal of Medical Research

Volumn 111, Issue MAR., 2000, Pages 81-89

  Krishnamoorthy, K ^a   Ramu, K ^a   Srividya, A ^a   Appavoo, N C ^b   Saxena, N B L ^b   Lal, Shiv ^b   Das, P K ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

^b Govt of Tamil Nadu ^*  (India)

Author keywords

Costing; Financial and opportunity costs; Lymphatic filariasis; Mass annual single dose DEC; PHC

Indexed keywords

DIETHYLCARBAMAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DOSE RESPONSE; DRUG COST; ENDEMIC DISEASE; FEMALE; FILARIASIS; GASTROINTESTINAL SYMPTOM; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POPULATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COST SAVINGS; DIETHYLCARBAMAZINE; DRUG COSTS; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; GUIDELINES; HUMANS; INFANT; MALE;

EID: 0033948089     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Bank. World Development Report. Investing in health (World development indicators). New York: Oxford University Press; 1993 p. 215-23.
2. Foster S, Phillips M. Economics and its contribution to the fight against malaria. Ann Trap Med Parasitol 1998; 92: 391-8.
3. Haddix AC, Shaffer PA. Cost effectiveness analysis. In: Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, editors. Prevention effectiveness. A guide to decision analysis and economic evaluation. Oxford: Oxford University Press; 1996 p. 103-29.
4. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. London: Oxford University Press; 1987 p. 39-167.
5. Evans DB, Gelband H, Vlassoff C. Social and economic factors and the control of lymphatic filariasis: a review. ActaTrop 1993; 53: 1-26.
6. Michael E, Meyrowitsch DW, Simonsen PE. Cost and cost effectiveness of mass diethylcarbamazine chemotherapy for the control of bancroftian filariasis: comparison of four strategies in Tanzania. Trop Med Int Health 1996; 1: 414-26.
7. Barlow R, Grober LM. Cost and benefits of controlling parasitic diseases, PHN Technical Note 85-17. Washington DC: Population, Health and Nutrition Department, The World Bank; 1985 p. 4-28.
8. World Health Organisation. The World Health Report 1996. Fighting disease fostering development. Geneva: World Health Organisation; 1996 p. 1-137.
9. World Health Organisation. Lymphatic filariasis infection and disease: Control strategies. Report of a WHO Consultative Meeting held at the Universiti Sains Malaysia, Penang, Malaysia. Document TDR/CTD/FIL/PENANG/94.1 Geneva: World Health Organisation; 1994 p. 1-30.
10. Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112: 409-28.
11. Sharma RS, Biswas H, Saxena NBL. National Filaria Control Programme. Operational manual. Delhi: National Malaria Eradication Programme; 1995 p.6.
12. Biswas G, Raina VK, Rao CK. A revised strategy for the control of lymphatic filariasis in India. Report and recommendations of the WHO Sponsored Workshop, Delhi: National Malaria Eradication Programme; 1996 p. 1-43.
13. Basu PC, Raghavan NGS, Gaur MP. Filariasis in India - facts and figures. Part X - Tamil Nadu. J Commun Dis 1971; 3: 113-25.
14. Ramakrishnan SP, Raghavan, NGS, Krishnaswamy AK, Nair CP, Basu PC, Singh D, et al. National Filaria Control Programme in India; a review. Indian J Malarial 1960; 14: 457-94.
15. Creese A, Parker D. Cost analysis in primary health care. A training manual for programme managers. Geneva: World Health Organization; 1994 p. 1-147.
16. Phillips M, Mills A, Dye C. Guidelines for cost-effectiveness analysis of vector control. Panel of Experts on Environmental Management for Vector Control. PEEM Guidelines series No. 3, Geneva: World Health Organisation; 1993 p. 1-192.
17. Guyatt H, Evans D, Lengeler C, Tanner M. Controlling schistosomiasis: the cost - effectiveness of alternative delivery strategies. Health Policy Planning 1994; 9: 385-95.
18. Clemmer B, Haddix AC. Cost benefit analysis. In: Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, editors. Prevention effectiveness. A guide to decision analysis and economic evaluation. Oxford: Oxford University Press; 1996 p. 85-102.
19. Rao CK, Chandrasekharan A, Kaul SM, Narasimham MVVL, Sharma SP. Relative effectiveness of different methods of control of Brugian filariasis in India. Indian J Med Res 1980; 72: 194-202.
20. Rao CK, Rao PP, Russel S, Hamzakoya KK, Chandrasekharan A, Roychowdhury SP, et al. Control of bancroftian filariasis with common salt medicated with diethylcarbamazine in Lakshadweep. Indian J Med Res 1981; 73: 865-73.
21. Sharma SP, Kosare GJ, Biswas H, Das M, Trivedi GK, Sharma GK. Control of Bancroftian filariasis in rural areas through selected treatment with diethylcarbamazine. J Commun Dis 1986; 18: 283-6.
22. Ramaiah KD, Ramu K, Guyatt H, Vijar Kumar KN, Pani SP. Direct and indirect costs of the acute form of lymphatic filariasis to households in rural areas of Tamil Nadu, south India. Trop Med Int Health 1998; 3: 108-15.
23. Sabesan S, Krishnamoorthy K, Pani SP, Panicker KN. Man days lost due to repeated acute attacks of lymphatic filariasis. Trends Life Sci 1992; 7: 5-7.
24. World Health Organization. Lymphatic filariasis: Reasons for hope. WHO/CTD/FIL/97.4 Geneva: World Health Organization; 1997 p. 1-20.
25. Kimura E, Spears GFS, Singh KI, Samarawickrema WA, Penaia L, Sone PF, et al. Long-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic Wuchereria bancrofti: eight years' experience in Samoa. Bull World Health Organ 1992; 70: 769-76.
26. Kimura E, Mataika JU. Control of lymphatic filariasis by annual single-dose diethylcarbamazine treatments. Parasitol Today 1996; 12: 240-4.
27. Addiss DG, Eberhard ML, Lammie PJ, McNeeley MB, Lee SH, McNeeley DF, et al. Comparative efficacy of clearing dose and single high dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaraemia. Am J Trap Med Hyg 1993; 48: 178-85.
28. Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea. Am J Trap Med Hyg 1993; 48: 804-11.
29. Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75: 491-503.
30. Rao CK, Sen T, Roychowdhury SP, Datta KK, Das M, Krishna Rao Ch, et al. Rural filariasis control with diethylcarbamazine. J Commun Dis 1978; 10: 194-6.